衰老和抗血栓治疗的治疗方法
Emanuele Valeriani1,2, Simona Bartimoccia3, Pasquale Pignatelli3
1Department of General Surgery, Surgical Specialties and Organ Transplantation "Paride Stefanini", Sapienza University of Rome, Rome, Italy.
Antioxidants & redox signaling
|September 24, 2023
概括
管理老年人血栓风险需要个性化抗血栓治疗. 平衡有效性和安全性对于减少老年人出血并发症至关重要.
科学领域:
- 老年学是一门学科.
- 心血管医学 心血管医学
- 血液学 血液学 血液学
背景情况:
- 衰老通过氧化应激,内皮功能障碍和改变的凝血增加了血栓形成的风险.
- 老年患者在临床试验中代表性不足,这使治疗指南复杂化.
- 在需要抗血栓治疗的老年患者中,管理出血风险是一个重大挑战.
研究的目的:
- 审查当前对与年龄相关的血栓形成机制的理解.
- 评估抗血栓策略,以减少老年人的心血管事件.
- 强调需要个性化治疗,平衡疗效和安全.
主要方法:
- 审查最近的随机试验和临床实践方面的考虑.
- 分析导致衰老中血栓形成的病理生理机制.
- 评估用于初级和二级预防的抗血栓药物选择.
主要成果:
- 由于出血风险,不建议进行常规抗血小板治疗作为初级预防.
- 对于急性冠状动脉综合征,请考虑低剂量普拉苏格勒/克洛皮多格勒和较短的双重抗血小板治疗.
- 直接口服抗凝剂比华法林更好,用于预防心房动中风,并仔细评估出血风险.
结论:
- 需要一个结构化,定制的方法来管理老年人的血栓形成风险.
- 抗血栓治疗决策必须个性化风险效益评估.
- 在老年人中,平衡抗血栓疗效与出血风险至关重要.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Low-Molecular-Weight Heparins
741
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
741
Atherosclerosis III: Management
11
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11


